Inbec国内上市时间

When will Suimeikai (Duotie Abalamid Tablets, Inbec) be launched in China? On January 20, 2018, GlaxoSmithKline China (GSK China) announced that its single-tablet compound preparation Suimeike (dolute abalamib tablets, Inbec) was officially launched in mainland China. This is the best-selling AIDS drug in the world in the past five years.

Suimeike (dolutegravir tablets, Inbec) was initially approved for marketing in the United States in 2014. It is currently the only three-in-one compound drug containing dolutegravir (DTG). Suimeikai (Dolutea Paramid Tablets, Inbec) has been approved for marketing in 50 countries and regions, and has been recommended by many authoritative academic institutions and authoritative guidelines in Europe and the United States as the first-line first-line treatment for patients with HIV infection.

The English name of Triumeq is Triumeq. Its ingredients are dolutegravir 50mg + abacavir 0.6g + lamivudine 0.3g. The method of taking it is very simple. Orally administered, one tablet once daily. It should be noted that the taking group is limited to adult patients weighing more than 40kg or adolescents over 12 years old.

In 1987, the first anti-HIV agent zidovudine (AZT) came out, which began to bring hope to HIV patients. With the continuous advancement of medical technology, more and more new drugs are on the market, providing patients with more choices. Integrate DTG (dolutegravir) was launched in China in 2016. It has remarkable effects and is very popular among patients. Suimeikai is a treatment plan with DTG, an integrase inhibitor, as the core drug, and two backbone drugs, lamivudine and abacavir, which reduces the patient's medication burden, has few side effects, is less likely to develop drug resistance, and improves the patient's quality of life.

Now, Suimeikai (Dolutea Paramid Tablets, Inbec) has been launched in more and more countries or regions, providing new treatment options for more HIV patients and bringing new hope.

The above is the domestic launch time of Suimeikai (Domitabalamid Tablets, Inbec) provided by our Medical Companion Travel Overseas Medical Consulting Service Company.